“5-Bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one targets prostate cancer cells by down-regulating inflammation-related genes” (2016) Bangladesh Journal of Pharmacology, 11(2), pp. 408–413. doi:10.3329/bjp.v11i2.23872.